• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病(COVID-19):血液学表现的简要综述

Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations.

作者信息

Słomka Artur, Kowalewski Mariusz, Żekanowska Ewa

机构信息

Department of Pathophysiology, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum, 85-094 Bydgoszcz, Poland.

Clinical Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, 02-607 Warsaw, Poland.

出版信息

Pathogens. 2020 Jun 20;9(6):493. doi: 10.3390/pathogens9060493.

DOI:10.3390/pathogens9060493
PMID:32575786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7350358/
Abstract

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus, but there are still no proven effective treatments. The present article reviews the common presenting hematological manifestations of coronavirus disease 2019 (COVID-19). Elucidating the changes in hematological parameters in SARS-CoV-2 infected patients could help to understand the pathophysiology of the disease and may provide early clues to diagnosis. Several studies have shown that hematological parameters are markers of disease severity and suggest that they mediate disease progression.

摘要

感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一场迅速蔓延且极具破坏性的全球大流行。许多研究人员正试图阐明感染机制并研发针对该病毒的药物或疫苗,但目前仍没有经证实有效的治疗方法。本文综述了2019冠状病毒病(COVID-19)常见的血液学表现。阐明SARS-CoV-2感染患者血液学参数的变化有助于理解该疾病的病理生理学,并可能为诊断提供早期线索。多项研究表明,血液学参数是疾病严重程度的标志物,并提示它们介导疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a8/7350358/6cce998b8294/pathogens-09-00493-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a8/7350358/efc3be95c6c0/pathogens-09-00493-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a8/7350358/6cce998b8294/pathogens-09-00493-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a8/7350358/efc3be95c6c0/pathogens-09-00493-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a8/7350358/6cce998b8294/pathogens-09-00493-g002.jpg

相似文献

1
Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations.2019冠状病毒病(COVID-19):血液学表现的简要综述
Pathogens. 2020 Jun 20;9(6):493. doi: 10.3390/pathogens9060493.
2
Immunological and Hematological Response in COVID-19.新型冠状病毒肺炎的免疫与血液学应答
Adv Exp Med Biol. 2021;1352:73-86. doi: 10.1007/978-3-030-85109-5_5.
3
It's in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19.血液中的奥秘:SARS-CoV-2 相关 COVID-19 患者血液系统综述。
Crit Rev Clin Lab Sci. 2023 Dec;60(8):595-624. doi: 10.1080/10408363.2023.2232010. Epub 2023 Jul 13.
4
SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children.严重急性呼吸综合征冠状病毒2感染:成人与儿童血液学参数的差异
Int J Gen Med. 2021 Jun 29;14:3035-3047. doi: 10.2147/IJGM.S313860. eCollection 2021.
5
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.新冠病毒肺炎患者细胞因子风暴及细胞因子靶向治疗的危害:综述
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.
6
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
9
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者:一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
10
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.

引用本文的文献

1
COVID-19 Challenges in Autoimmune Hepatitis Management: A Successful Outcome With Intravenous Immune Globulin (IVIg).自身免疫性肝炎管理中的新冠疫情挑战:静脉注射免疫球蛋白(IVIg)治疗的成功案例
Case Rep Gastrointest Med. 2025 Apr 7;2025:4446896. doi: 10.1155/crgm/4446896. eCollection 2025.
2
The Role of Dynamic Changes in Hematologic and Biochemical Parameters in Predicting Mortality in Covid-19 Patients.血液学和生化参数动态变化在预测新冠病毒肺炎患者死亡率中的作用
Sisli Etfal Hastan Tip Bul. 2024 Sep 30;58(3):371-380. doi: 10.14744/SEMB.2024.26096. eCollection 2024.
3
Dynamic changes of hematological and hemostatic parameters in COVID-19 hospitalized patients: Potential role as severity biomarkers for the Chilean population.

本文引用的文献

1
Current Understanding of COVID-19 Clinical Course and Investigational Treatments.对新型冠状病毒肺炎临床病程及试验性治疗的当前认识。
Front Med (Lausanne). 2020 Oct 21;7:555301. doi: 10.3389/fmed.2020.555301. eCollection 2020.
2
Associations between blood type and COVID-19 infection, intubation, and death.血型与 COVID-19 感染、插管和死亡之间的关联。
Nat Commun. 2020 Nov 13;11(1):5761. doi: 10.1038/s41467-020-19623-x.
3
Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility.ABO 血型与 2019 年冠状病毒病(COVID-19)易感性的关系。
新冠病毒肺炎住院患者血液学和止血参数的动态变化:对智利人群作为疾病严重程度生物标志物的潜在作用
J Med Biochem. 2024 Jun 15;43(4):556-564. doi: 10.5937/jomb0-47588.
4
Hematological profile, inflammatory markers and serum liver enzymes in COVID 19 positive children vs. COVID 19 negative ones-a comparative study.新冠病毒 19 阳性儿童与新冠病毒 19 阴性儿童的血液学指标、炎症标志物及血清肝酶——一项对比研究。
Front Pediatr. 2024 Feb 15;12:1334591. doi: 10.3389/fped.2024.1334591. eCollection 2024.
5
Molecular Amplification and Cell Culturing Efficiency for Enteroviruses' Detection in Cerebrospinal Fluids of Algerian Patients Suffering from Meningitis.分子扩增和细胞培养效率在阿尔及利亚脑膜炎患者脑脊液中肠道病毒检测的应用。
Viruses. 2024 Jan 23;16(2):170. doi: 10.3390/v16020170.
6
Impact of ABO Blood Group, Hematological, and Biochemical Abnormalities on Incidence of Patients Infected with COVID-19.ABO 血型、血液学和生物化学异常对 COVID-19 感染患者发病率的影响。
Arch Razi Inst. 2023 Aug 31;78(4):1193-1201. doi: 10.32592/ARI.2023.78.4.1193. eCollection 2023 Aug.
7
Early Outcome of Multisystem Inflammatory Syndrome in Neonates Diagnosed following Prenatal Maternal COVID-19 Infection: A Three-Case Series.产前母亲感染新冠病毒后诊断出的新生儿多系统炎症综合征的早期结局:三例病例系列
Pediatr Rep. 2023 Oct 10;15(4):591-598. doi: 10.3390/pediatric15040054.
8
Leukopenia and leukocytosis as strong predictors of COVID-19 severity: A cross-sectional study of the hematologic abnormalities and COVID-19 severity in hospitalized patients.白细胞减少和白细胞增多作为新冠病毒疾病严重程度的有力预测指标:一项关于住院患者血液学异常与新冠病毒疾病严重程度的横断面研究
Health Sci Rep. 2023 Sep 27;6(10):e1574. doi: 10.1002/hsr2.1574. eCollection 2023 Oct.
9
Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes.COVID-19 后缺血性中风的遗传结构与大动脉性中风相似。
Int J Mol Sci. 2023 Aug 30;24(17):13452. doi: 10.3390/ijms241713452.
10
Hematological alterations associated with long COVID-19.与新冠长期症状相关的血液学改变。
Front Physiol. 2023 Jul 24;14:1203472. doi: 10.3389/fphys.2023.1203472. eCollection 2023.
Clin Infect Dis. 2021 Jul 15;73(2):328-331. doi: 10.1093/cid/ciaa1150.
4
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.基于中性粒细胞与淋巴细胞比值和IgG水平的免疫表型分析可预测COVID-19患者的疾病严重程度和预后。
Front Mol Biosci. 2020 Jul 3;7:157. doi: 10.3389/fmolb.2020.00157. eCollection 2020.
5
A proposal for staging COVID-19 coagulopathy.关于新冠病毒感染相关凝血功能障碍分期的一项提议。
Res Pract Thromb Haemost. 2020 Jul 6;4(5):731-736. doi: 10.1002/rth2.12372. eCollection 2020 Jul.
6
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.撤回说明:严重急性呼吸综合征冠状病毒2通过其刺突蛋白介导的膜融合感染T淋巴细胞。
Cell Mol Immunol. 2020 Aug;17(8):894. doi: 10.1038/s41423-020-0498-4.
7
Thromboelastometry and D-Dimer Elevation in Coronavirus-2019.2019冠状病毒病中的血栓弹力图和D-二聚体升高
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3495-3496. doi: 10.1053/j.jvca.2020.05.020. Epub 2020 May 21.
8
ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.新冠住院患者的ADAMTS13活性、血管性血友病因子、凝血因子VIII及D-二聚体
Thromb Res. 2020 Aug;192:174-175. doi: 10.1016/j.thromres.2020.05.032. Epub 2020 May 23.
9
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.在患有新冠肺炎、急性呼吸窘迫综合征和炎症反应过度的患者中使用高剂量阿那白滞素进行白细胞介素-1阻断:一项回顾性队列研究。
Lancet Rheumatol. 2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.
10
Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study.危重症COVID-19患者的血栓形成和出血事件:一项法国单中心回顾性研究。
Crit Care. 2020 Jun 2;24(1):275. doi: 10.1186/s13054-020-03025-y.